Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia

Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia

ObjectsThis study aimed to investigate the expression patterns and clinical significance of neural cell adhesion molecule-positive (CD56+) myelomonocytes in pediatric patients with moderate aplastic anemia (mAA).MethodsFifty-six pediatric patients with mAA were enrolled in this study. The patients&#...

Full description

Bibliographic Details
Main Authors: Shanshan Qi, Yu Du, Ming Sun, Lin Zhang, Zhi Chen, Hao Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pediatrics
Subjects:
CD56+ myelomonocytes
cyclosporine
moderate aplastic anemia
pediatric aplastic anemia
response
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1272593/full

Similar Items

Similar Items